A study comparing efficacy of denosumab versus bisphosphonates in patients with rheumatoid arthritis
Latest Information Update: 03 Jan 2017
Price :
$35 *
At a glance
- Drugs Denosumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 24 Aug 2016 New trial record